ARTES brings new vaccine advances to veterinary ‘Dragons’ Den’

ARTES will attend February’s European Animal Health Investment Forum in London and will present its innovative technologies to potential partners
This will be ARTES’ second participation in the high prestige investment networking event, which is seen as the ‘Dragons’ Den’ of veterinary medicine.
ARTES Managing Director, Dr. Michael Piontek, will use the forum to talk with interested parties about latest developments of the laboratory’s innovative proprietary vaccine development platform, METAVAX®, which received a new EU-based grant of patent last August.
Meet us at the European Animal Health Investment Forum tak­ing place in London, February 20 -21. Con­tact us pre­vi­ous­ly for orga­niz­ing a per­son­al meet­ing or drop us a notice via the part­ner­ing sys­tem. We look for­ward to meet­ing you!